Qiagen NV

Healthcare · Diagnostics & Research

43.30$ -2.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Qiagen NV (QGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 2,090 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement QGEN
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	54	74	110	144	204	264	299	351	381	398	466	650	893	1,010	1,087	1,170	1,254	1,302	1,345	1,281	1,338	1,418	1,502	1,526	1,870	2,252	2,142	1,965	1,978	2,090
Cost of Revenue	12	15	32	37	65	80	97	122	127	123	141	216	293	343	372	420	430	486	480	454	493	495	501	521	638	801	757	732	1,011	799
Gross Profit	42	59	89	121	151	184	202	229	254	275	325	434	600	667	716	750	824	815	865	827	845	923	1,001	1,005	1,233	1,451	1,385	1,234	967	1,291
Research & Development	6.5	8.3	13	16	22	27	28	32	34	39	42	65	97	108	126	131	122	146	164	147	176	154	162	157	149	190	190	199	193	188
Selling, General & Administrative	–	–	50	61	82	101	117	125	129	135	165	237	341	116	110	186	152	199	127	104	129	200	141	112	112	128	130	119	113	126
Total Operating Expenses	36	51	73	98	115	131	159	160	169	180	224	350	454	487	527	650	654	752	704	647	746	769	734	1,031	846	821	853	824	870	771
Operating Income	6.0	8.3	16	23	37	53	43	69	84	95	101	83	146	180	189	100	170	63	162	179	99	153	267	-26	386	630	531	410	98	520
Interest Expense	0.0	0.0	0.0	0.0	0.0	0.0	2,565	4,647	5,101	5,940	11,918	31,455	38	30	28	25	23	31	39	37	39	50	67	74	71	54	58	53	44	33
Pre-Tax Income	8.6	14	19	25	39	56	39	67	73	97	106	76	119	172	173	96	145	37	119	136	57	114	226	-78	439	626	513	430	121	490
Income Tax Expense	3.3	4.8	5.5	11	18	22	16	24	24	35	36	26	30	35	29	1.3	16	-32	2.5	6.4	-23	74	35	-36	80	113	89	89	38	65
Net Income	5.3	8.8	13	14	21	34	23	43	49	62	71	50	89	138	144	96	130	69	116	130	80	40	190	-41	359	513	423	341	84	425
EBITDA	8.5	13	28	46	47	69	82	98	111	126	140	195	263	322	344	289	366	268	360	365	309	381	499	228	716	895	779	689	368	717

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings